New Advances in Dyslipidemia
Dublin Core
Title
New Advances in Dyslipidemia
Subject
Medicine and Nursing
Description
Dyslipidemia is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). However, despite current traditional therapies (e.g., statins), significant residual risks for the onset of ASCVD remain, warranting the need to better understand newer therapeutic options for diminishing this prospect. This Special Issue will discuss state-of-the-art clinical trials and other research developments regarding newer and emerging therapies for the management of dyslipidemia to reduce the residual risks of ASCVD.
Creator
Nathan Wong
Source
https://mdpi-res.com/bookfiles/book/8654/New_Advances_in_Dyslipidemia.pdf?v=1757466464
Publisher
MDPI - Multidisciplinary Digital Publishing Institute
Date
2024
Contributor
Mustabsyirah
Rights
Creative Commons
Format
PDF
Language
English
Type
Textbooks
Files
Collection
Citation
Nathan Wong, “New Advances in Dyslipidemia,” Open Educational Resource (OER) - USK Library, accessed January 31, 2026, http://oer.usk.ac.id/items/show/9121.